Andrew David William Newland

Founder at ANGLE plc

Andrew David William Newland

Andrew David William Newland

Founder at ANGLE plc

Overview
Career Highlights

Novocellus Ltd.
ANGLE plc
Acolyte Biomedica Ltd.

RelSci Relationships

52

Number of Boards

4

Birthday

1961

Age

57

Relationships

Chief Financial Officer, Secretary & Executive Director at ANGLE plc

Founder at Momentum Bioscience Ltd.

Chief Scientific Officer at Parsortix, Inc.

Chief Technology Officer at ANGLE plc

Non-Executive Director at NeuroTargets Ltd.

Former Executive Chairman at Ultrafine Ltd. (Gillingham)

President, Chief Executive Officer & Director at Axela, Inc.

Director-Business Development at ANGLE plc

Director-Operations & Regulatory Affairs at ANGLE plc

Former Chief Executive Officer at Comino Group Plc

Subscribe to RelSci Professional to see 52 more Relationships
Paths to Andrew David William Newland
Potential Connections via
Relationship Science
You
Andrew David William Newland
Founder at ANGLE plc
Education
MA in Engineering Science

The University of Cambridge (informally known as Cambridge University or Cambridge) is a public research university located in Cambridge, United Kingdom. It is the second-oldest university in the English-speaking world (after the University of Oxford), and the seventh-oldest in the world.

Career History
Founder
1994 - Current

ANGLE Plc operates as a holding company, through its subsidiaries engages in providing products in cancer diagnostics and foetal health. Its main product is the Parsortix cell separation system, which can capture very rare cells from blood. The company was founded by Andrew D. W. Newland in April 1994 and is headquartered in Guildford, the United Kingdom.

Chairman
Current
Co-Founder
1999 - Prior

Acolyte Biomedica Ltd. develops, manufactures, and markets microbiology and cell enumeration systems for clinical diagnostics and life sciences research. Its products include baclite rapid and rapitect. The company was founded in February 2000 and is headquartered in Salisbury, UK.

Subscribe now for extended career history
Boards & Committees
Chairman
Current
Chairman
Current
Chairman
Current

NeuroTargets, Inc. develops novel therapeutic products. It discovers and develops new drugs for neurological diseases. The company develops products in the fields of diabetic neuropathy, pain resulting from nerve damage, spinal cord injuries and other trauma, and brain diseases associated with cognitive impairment such as stroke and Alzheimer's disease. NeuroTargets was founded in 1999 and is located at Guildford, UK.

Subscribe now to see 1 more corporate board memberships
Subscribe now to see non-profit board memberships for over 7 million people
Subscribe now to see government board memberships for over 7 million people
Public Holdings
Restricted data only for RelSci Professional users.
Subscribe now to see public holdings for over 7 million people
Other Affiliations